NCT04689828
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04689828
Title 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
Acronym PSMAfore
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | SVK | POL | NLD | GBR | FRA | ESP | DEU | CZE | CHE | CAN | BEL | AUT

Facility Status City State Zip Country Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
University of Florida Gainesville Florida 32610 United States Details
Tulane Uni Health Sciences Center New Orleans Louisiana 70112 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Beth Israel Deaconess Med Ctr Boston Massachusetts 02215 United States Details
WA Uni School Of Med St Louis Missouri 63110 United States Details
Urology Cancer Center PC Omaha Nebraska 68130 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68154 United States Details
NYU Laura and Isaac Perlmutter Cancer Center New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Ctr New York New York 10017 United States Details
Mount Sinai Hosp Med School New York New York 10029 United States Details
Duke Univ Medical Center Durham North Carolina 27710 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43221 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Uni Of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Utah Cancer Specialists Salt Lake City Utah 84106 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Onco Hemato Asso of SE Virginia Roanoke Virginia 24014 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Medical College Of Wisconsin Milwaukee Wisconsin 53226 United States Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Linz 4020 Austria Details
Novartis Investigative Site Vienna 1090 Austria Details
Novartis Investigative Site Roeselare West-Vlaanderen 8800 Belgium Details
Novartis Investigative Site Brussels 1200 Belgium Details
Novartis Investigative Site Ghent 9000 Belgium Details
Novartis Investigative Site Liège 4000 Belgium Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site Montreal Quebec H2W 1T8 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Olomouc 779 00 Czechia Details
Novartis Investigative Site Angers 49055 France Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Clermont-Ferrand 63011 France Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Paris 75970 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site München 80377 Germany Details
Novartis Investigative Site Nijmegen Gelderland 6500HB Netherlands Details
Novartis Investigative Site Maastricht Limburg 6229 HX Netherlands Details
Novartis Investigative Site Utrecht 3584 CX Netherlands Details
Novartis Investigative Site Gliwice Silesian Voivodeship 44-101 Poland Details
Novartis Investigative Site Bratislava 83310 Slovakia Details
Novartis Investigative Site Santiago Compostela A Coruna 15706 Spain Details
Novartis Investigative Site L'Hospitalet de Llobregat Barcelona 08907 Spain Details
Novartis Investigative Site Barcelona Catalonia 08035 Spain Details
Novartis Investigative Site Majadahonda Madrid 28222 Spain Details
Novartis Investigative Site El Palmar Murcia 30120 Spain Details
Novartis Investigative Site Pamplona Navarre 31008 Spain Details
Novartis Investigative Site Valencia Valencia 46009 Spain Details
Novartis Investigative Site Barcelona 08036 Spain Details
Novartis Investigative Site Barcelona 08041 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Málaga 29010 Spain Details
Novartis Investigative Site Seville 41013 Spain Details
Novartis Investigative Site Valencia 46026 Spain Details
Novartis Investigative Site Gothenburg 413 45 Sweden Details
Novartis Investigative Site Lund 221 85 Sweden Details
Novartis Investigative Site Stockholm 17176 Sweden Details
Novartis Investigative Site Baden 5404 Switzerland Details
Novartis Investigative Site Lausanne 1011 Switzerland Details
Novartis Investigative Site Zurich 8091 Switzerland Details
Novartis Investigative Site Guildford Surrey GU2 7XX United Kingdom Details
Novartis Investigative Site Sutton Surrey SM2 5PT United Kingdom Details
Novartis Investigative Site Coventry CV2 2DX United Kingdom Details
Novartis Investigative Site London EC1A 7BE United Kingdom Details
Novartis Investigative Site London NW1 2BU United Kingdom Details
Novartis Investigative Site London NW3 2QG United Kingdom Details
Novartis Investigative Site Middlesbrough TS4 3BW United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field